Close
Digital Health & Ai Innovation summit 2026
APE 2026

News

Ampio announces successful Pre-IND meeting with the Ophthalmology Division of the FDA on Optinaa

Ampio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing drugs for the treatment of inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male...

Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in

 Biodel Inc.announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the...

Pancreatic Cancer Risk May Be Reduced By High Dietary Antioxidant Intake

Individuals can significantly reduce their risk of developing pancreatic cancer by increasing their dietary intake of the antioxidant vitamins C, E, and selenium, say researchers...

FDA Approves First Drug To Reduce Risk Of HIV Infection

The US Food and Drug Administration (FDA), announced on Monday that it has approved a existing drug, Truvada for reducing risk of infection by sexually...

For Patients With Acute Myeloid Leukemia, Mutation In Gene IDH A Possible Target For Treatment

Many patients with acute myeloid leukemia (AML) share a mutation in a gene called IDH. A University of Colorado Cancer Center study published this week...

Hormone Replacement Therapy Started Early Increases Synapses In Rat Prefrontal Cortex

A new study of aged female rats found that long-term treatment with estrogen and a synthetic progesterone known as MPA increased levels of a protein...

DNA From Cystic Fibrosis Patients With And Without Chronic Infections Points To Unsuspected Mutation

Comparing the DNA from patients at the best and worst extremes of a health condition can reveal genes for resistance and susceptibly. This approach discovered...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »